XERIS BIOPHARMA HOLDINGS, INC. (XERS) Total assets 2020–2025
XERIS BIOPHARMA HOLDINGS, INC. (XERS) total assets at each fiscal year-end, per SEC filings.
$383.5MFY2025 · since FY2020: $159.2M → $383.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $383.5M | +18.7% |
| FY2024 | $323.1M | +0.1% |
| FY2023 | $322.6M | -6.4% |
| FY2022 | $344.5M | +13.2% |
| FY2021 | $304.4M | +91.2% |
| FY2020 | $159.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More XERS financial trends
XERS RevenueXERS Net incomeXERS Net marginXERS Gross profitXERS Gross marginXERS Operating incomeXERS Operating marginXERS Operating cash flowXERS Free cash flowXERS Capital expendituresXERS Return on equityXERS Stock buybacksXERS Dividends paidXERS Total liabilitiesXERS Shareholders’ equityXERS overview →